Journals / Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi / 2021 / Cilt: 10 - Sayı: 3

Pharmacological Activities of Extracts and Isolated Phytochemical Constituents of Pandanus Odorifer (Forssk.) Kuntze

Pages
574–580
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This work provides a basis for further pharmacological and phytochemical researches using P. odorifer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pandanus odorifer (Forssk.) Kuntze belongs to the Pandanaceae family.
📊
Key Findings & Data:The major electronic databases (Web of Science, PubMed, ScienceDirect, and Scopus) were applied to identify the relevant published studies from 1900 to June 2021.
💡
Conclusion & Impact:This work provides a basis for further pharmacological and phytochemical researches using P. odorifer.
🔬Design:Review & Systematic Survey
📍Scope:2021 Verileri
⚙️Variables:Pandanus odorifer · Pandanaceae · Sri Lanka

Abstract

Pandanus odorifer (Forssk.) Kuntze belongs to the Pandanaceae family. P. odorifer is used in traditional medicines to treat diabetes, jaundice, skin diseases, brain disorders, and urinary tract illnesses. This work aims to present a comprehensive review to analyze, summarize, and document the reported pharmacological activities of this plant species. Compounds such as eugenol, capric acid, germacrene B, camphor, and linalool have been discovered in this plant species. The major electronic databases (Web of Science, PubMed, ScienceDirect, and Scopus) were applied to identify the relevant published studies from 1900 to June 2021. In vitro and in vivo level of scientific evidence of pharmacological activities of various extracts and active compounds of this plant species is available at the moment. Pharmacological investigations show that P. odorifer possesses such as antioxidant, chemoprotective, antidepressant, antidiabetic, anti-inflammatory, and hepatoprotective activities. This work provides a basis for further pharmacological and phytochemical researches using P. odorifer.

Özet

Pandanus odorifer (Forssk.) Kuntze belongs to the Pandanaceae family. P. odorifer is used in traditional medicines to treat diabetes, jaundice, skin diseases, brain disorders, and urinary tract illnesses. This work aims to present a comprehensive review to analyze, summarize, and document the reported pharmacological activities of this plant species. Compounds such as eugenol, capric acid, germacrene B, camphor, and linalool have been discovered in this plant species. The major electronic databases (Web of Science, PubMed, ScienceDirect, and Scopus) were applied to identify the relevant published studies from 1900 to June 2021. In vitro and in vivo level of scientific evidence of pharmacological activities of various extracts and active compounds of this plant species is available at the moment. Pharmacological investigations show that P. odorifer possesses such as antioxidant, chemoprotective, antidepressant, antidiabetic, anti-inflammatory, and hepatoprotective activities. This work provides a basis for further pharmacological and phytochemical researches using P. odorifer.

🔖

Cite This Article

SATHASIVAMPILLAI, S. V., RAJAMANOHARAN, P. R. S., SHANMUGALINGAM, V. (2022). Pharmacological Activities of Extracts and Isolated Phytochemical Constituents of Pandanus Odorifer (Forssk.) Kuntze. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 10 - Sayı: 3, 574–580. https://ajindex.com/articles/527321

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Bown, D. (1995). “Encyclopedia of Herbs and Their Uses”. Dorling Kindersley. Gamble, J.S. (1881). “A Manual of Indian Timbers: An Account of the Growth, Distribution, and Uses of the Trees and Shrubs of India and Ceylon, with Descriptions of Their Wood-structure”. S. Low, Marston & Company Limited. Watt, S.G. (1908). The Commercial Products of India: Being an Abridgement of The Dictionary of the Economic Products of India. London. Low, T. (1991). Wild Food Plants of Australia. Angus & Robertson. Ilanchezhian, R. and Joseph, R. (2006). “Hepatoprotective and hepatocurative activity of the traditional medicine ketaki (Pandanus odoratissimus Roxb.)”. Asian Journal of Traditional Medicines, 5, 212–218.
  2. Jain, S.K. (1991). Dictionary of Indian folk medicine and ethnobotany. Deep publications. Khare, C.P. (2011). Indian Herbal Remedies: Rational Western Therapy, Ayurvedic and Other Traditional Usage, Botany. Springer-Verlag Berlin Heidelberg. Kirtikar, K.R. and Basu, B.D. (1935).
  3. Indian Medicinal Plants, Vol. II. Allahabad: Lalit Mohan Publication. Raina, V.K, Kumar, A, Srivastava, S.K, Syamsundar, K.V. and Kahol, A.P. (2004). “Essential oil composition of ‘kewda’(Pandanus odoratissimus) from India”. Flavour and Fragrance Journal, 19, 434–436.
  4. Sathasivampillai, S.V, Rajamanoharan, P.R.S, Heinrich, M. and Munday, M. (2015). “Preparations and plants used to treat diabetes in Sri Lankan Siddha Medicine”. Presented at the 3rd International Conference on Ayurveda, Unani, Siddha and Traditional Medicine, Institute of Indigenous Medicine, University of Colombo, Colombo, 67. Sathasivampillai, S.V, Rajamanoharan, P.R.S, Munday, M. and Heinrich, M. (2016). “Plants used to treat diabetes in Sri Lankan Siddha Medicine – An ethnopharmacological review of historical and modern sources”. Journal of Ethnopharmacology, 198, 531–599. https://doi.org/10.1016/j.jep.2016.07.053.
  5. Sathasivampillai, S.V, Rajamanoharan, P.R.S, Munday, M. and Heinrich, M. (2017). “Plants currently used to treat diabetes in Sri Lankan Siddha Medicine – an ethnobotanical survey in the Eastern Province”. Presented at the World Congress Integrative Medicine & Health 2017: part three, Springer Nature, Berlin, Germany, 333. https://doi.org/10.1186/s12906-017-1784-2.
  6. Sathasivampillai, S.V, Rajamanoharan, P.R.S, Munday, M. and Heinrich, M. (2018). “Siddha medicine in eastern Sri Lanka today–continuity and change in the treatment of diabetes”. Frontiers in Pharmacology, 9, 1022. Warrier, P.K, Nambiar, V.P.K. and Ra